Therefore, one may speculate that the ability of copeptin to predict metabolic disease might differ between Middle Eastern and Swedish ethnicity, for example due to differences in expression or function of VP-receptors, making individuals from Iraq more susceptible to VP-exposure. The gene discussed is AVP; the disease is metabolic disease.